PERSISTENCE OR DEVELOPMENT OF NEW ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY BY BOTH CORNELL PRODUCT AND SOKOLOW-LYON VOLTAGE IS ASSOCIATED WITH MARKEDLY INCREASED RISK DURING ANTIHYPERTENSIVE THERAPY

Abstract

Hypertensive patients with ECG left ventricular hypertrophy (LVH) are at increased risk, but single ECG criteria may underestimate risk. Whether the continued presence or new development of ECG LVH by two criteria can further concentrate risk during blood pressure (BP) lowering is unclear. Incident